DudeMeds review

Compare a complete offer, not the word monthly

The current weight page identifies semaglutide + vitamin B6 and tirzepatide + vitamin B6 as compounded prescription options. The introductory offers are $99 and $149 respectively, each a one-time amount for four weeks if prescribed. They explicitly say no automatic renewal. ^[1]

That is a different purchase from a continuing monthly subscription. I would compare the medicine, supplied period and actual total together. The card’s weekly equivalent is an arithmetic comparison figure, not a promise that payments can be made weekly or that the introductory price continues.

Compare paid amounts over the same supplied period in the cost planner.

The next supply has its own price and review

The product pages separately list eight-week Kickstart offers: $392 for semaglutide and $472 for tirzepatide. Other continuation listings have different totals, and the pages say continuing care requires patient questions and provider review. ^{[2] [3]}

I would ask which offer fits the actual prescription and treatment history. A listed schedule helps identify a commercial configuration; it should not choose the patient’s dose. Do not infer the next paid order by extending the introductory four-week price or selecting the cheapest higher-strength card.

For a distinct recurring billing model, read our Wellorithm review.

B6 is an ingredient, not evidence of a better result

The product names identify compounded preparations with vitamin B6. The opened B6 answer says the ingredient is listed without a claim that adding it improves weight loss, reduces nausea or makes the preparation equivalent to an approved medicine. ^[3]

That limitation is useful. The pages also state that FDA has not reviewed these preparations for safety, effectiveness or quality. ^{[1] [2]} I would keep the actual formulation in the comparison and ask the clinician which evidence applies, rather than transfer a branded trial result to the purchased compound.

Keep preparation and route distinct with our product-format evidence guide.

An offer selection does not settle clinical access

The public process separates browsing from secure medical intake, with the clinician deciding whether to prescribe and giving treatment instructions. The offers are excluded in Alabama, Arkansas, California, Kentucky and South Carolina. ^[1] A visible price card is not an eligibility decision.

The terms say a prescription request may require more information and a rejected request is not charged. ^[4] I would confirm that the selected order follows that condition and ask who handles questions after dispensing. No clinical form or purchase was completed for this review.

Compare another clinician and pharmacy arrangement in our Push Health review.

The general sale terms need a product-specific answer

The current product pages say one-time purchase and no automatic renewal. Billing help separately explains that a supply period alone does not establish subscription terms. ^{[2] [3] [5]} However, the sale terms still contain recurring-plan language, pre-dispatch charging and a first-three-month medication-payment paragraph. ^[4]

I would get written confirmation of which clauses apply before authorizing the order. The terms also limit prescription returns and refunds after processing or dispensing, while preserving remedies for certain defects and errors. A one-time card is not an unconditional money-back promise, and an older general clause should not silently be turned into a definite recurring charge for this new offer.

For a separate membership-and-medication model, compare our Hone Health review.

My shortlist depends on a coherent order agreement

DudeMeds is worth comparing when the reader prefers a defined purchase over automatic renewal and understands how a later supply is reviewed. The current cards make the supply and one-time total clearer than a broad starting monthly headline.

I would still settle the selected preparation, pharmacy, complete charge and follow-up responsibility together. If the product page and general terms leave different impressions about future obligations, resolve that before paying. The strongest reason to choose is a suitable clinical arrangement with understandable purchase terms, not the smallest introductory number.

Build a like-for-like shortlist with our provider comparisons.

Understanding the cost

Semaglutide + B6 First Month Intro $99 one-time for four weeks; tirzepatide + B6 First Month Intro $149 one-time for four weeks, if prescribed. Eight-week Kickstart offers $392/$472 respectively. These are different one-time offers, not ongoing monthly rates; weekly equivalents are not weekly billing. General sale terms still contain recurring and three-month clauses; confirm the actual selected agreement and any additional charges. ^{[1] [2] [3] [4]}